"10.1371_journal.pone.0007865","plos one","2009-11-17T00:00:00Z","Rogier M Thurlings; Carla A Wijbrandts; Roelof J Bennink; Serge E Dohmen; Carlijn Voermans; Diana Wouters; Elena S Izmailova; Danielle M Gerlag; Berthe L F van Eck-Smit; Paul P Tak","Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Noord Holland, The Netherlands; Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Noord Holland, The Netherlands; Landsteiner Laboratory, Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Noord Holland, The Netherlands; Department of Immunopathology, Sanquin Research, Amsterdam, Noord Holland, The Netherlands; Millennium Pharmaceuticals, Inc, Department of Research and Development, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: RMT CAW RJB SED CV DW ESI DMG BLFvES PPT. Performed the experiments: RMT CAW RJB SED CV DW. Analyzed the data: RMT CAW RJB SED DW ESI PPT. Contributed reagents/materials/analysis tools: RJB SED CV DW ESI BLFvES PPT. Wrote the paper: RMT CAW RJB SED CV DW ESI DMG BLFvES PPT.","Millennium Pharmaceuticals Inc. (Cambridge, Massachusetts) was involved in the study design and supported the study. Millennium does not hold any IP (patent) applications with claims relevant to the materials or assays described in the manuscript. Millennium might consider using the monocyte scan described in the manuscript for the evaluation of novel antirheumatic drugs in the future.","2009","11","Rogier M Thurlings","RMT",10,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
